SBIR/STTR Research Award
Transplacental Detection of Mutagenesis
Award amount
$96,797Program and phase
SBIR · Phase IAward year
1995Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- INTEGRATED LABORATORY SYSTEMS, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- RWSSJRJLCDM4
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Exposure of animals and man during development can result in teratogenic, mutagenic, and carcinogenThis research will determine whether transgenic mouse models used for mutagenicity testing can be ustransplacental mutagens. Phase I will be a proof-of-principle study to demonstrate the applicabilityknown mutagen. In Phase II, the assay will be further characterized using additional chemicals and dprotocols, as well as by determining whether or not the mutant spectra of the mutagen of interest istissue of the mother and her offspring. This assay will be used to identify transplacental mutagensopportunity of determining whether mutations which occur during development are related to teratogenoutcomes.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Mutational profiling in human cells as an in vitro alternative to in vivo mutagenicity assessments
- CometChip: Development of a high throughput DNA damage assay in hepatocytes
- Assay Development for Measuring Chemical Effects on the Epigenome in Stem Cells
- CometChip: Development of a high throughput DNA damage assay in hepatocytes
- CometChip: Development of a high throughput DNA damage assay in hepatocytes